Redox regulation of MMP-3/TIMP-1 ratio in intestinal myofibroblasts: effect of N-acetylcysteine and curcumin.
Study Design
- Tipo de estudio
- In Vitro
- Población
- Intestinal myofibroblasts from Crohn's disease patients
- Intervención
- Redox regulation of MMP-3/TIMP-1 ratio in intestinal myofibroblasts: effect of N-acetylcysteine and curcumin. None
- Comparador
- None
- Resultado primario
- MMP-3/TIMP-1 ratio in intestinal myofibroblasts
- Dirección del efecto
- Positive
- Riesgo de sesgo
- Unclear
Abstract
Matrix metalloproteinases (MMPs) play a critical role in inflammation and ulcerations in gut of Crohn׳s disease (CD) patients. Intestinal subepithelial myofibroblasts (ISEMFs) secrete MMPs in response to inflammatory stimuli. Previous data showed in CD-ISEMFs increased oxidative status. The aim of this study was to investigate the role of ISEMFs in modulating the production of MMP-3 and TIMP-1, an inhibitor of MMPs activity. A relationship among oxidative stress, activity of antioxidants and MMP-3/TIMP-1 was also studied. ISEMFs isolated from CD patient colon and human colonic cell line of myofibroblasts (18Co) were used. Oxidative state was modulated by buthionine sulfoximine, an inhibitor of glutathione (GSH) synthesis, and N-acetylcysteine (NAC), GSH precursor. An up-regulation of MMP-3 due to increased oxidative state was found in CD-ISEMFs. Stimulation by tumor necrosis factor (TNF)α increased further MMP-3 levels. On the contrary, no change in TIMP-1 production was determined. NAC treatment decreased MMP-3 production in CD-ISMEFs and removed the enhancement due to TNFα. Similar effects were observed in 18Co cells treated with curcumin, antioxidant with anti-inflammatory properties. The involvement of MAPKs on MMP-3 redox regulation was also shown. This study demonstrates the involvement of ISEMFs and high oxidative state in the increased MMP-3 production found in intestinal mucosa of CD patients. NAC and curcumin normalize MMP-3 levels mainly in TNFα stimulated cells. A modulation of MMP-3 production by NAC and curcumin due to their direct action on transcriptional factors has been also suggested. Therefore, they could have a therapeutic use for the prevention and treatment of fistulaes in CD.
TL;DR
The involvement of ISEMFs and high oxidative state in the increased MMP-3 production found in intestinal mucosa of CD patients is demonstrated and could have a therapeutic use for the prevention and treatment of fistulaes in CD.
Used In Evidence Reviews
Similar Papers
The AAPS journal · 2013
Therapeutic roles of curcumin: lessons learned from clinical trials.
Digestive diseases and sciences · 2005
Curcumin therapy in inflammatory bowel disease: a pilot study.
Molecular nutrition & food research · 2013
Multitargeting by turmeric, the golden spice: From kitchen to clinic.
Gastroenterology · 2017
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
Frontiers in endocrinology · 2023
Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease.
Journal of nanobiotechnology · 2022